PIK3CA (N = 8, 61.5%), TP53 (N = 5, 38.5%), FBXW7 (N = 3, 23.1%), ERBB2 (N = 2, 15.4%), and PTEN (N = 2, 15.4%) were most common in cervical cancer patients. This evidence concerns the gene PTEN and cervical carcinoma.